Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ok ok now we all know this stock is governed by dark forces ... farnesene is the next food of the beast ...
thank you so much
Is someone philanthropist here or simply the greatest bear I have seen in all my life ?
We all know the bad past of this company ... here we are speaking of a new company with new products and new CFO .
I know all ... don't worry ... those are the reasons for Amyris is a penny stock ...
Future could be the same with more debt and dilution or we'll finally have cash flow positive and reduction of debt and dilution ...
Is Nostradamus posting here ?
Nostradamus cannot answer to my questions I know ... he doesn't like answer but only sentence ...
So we'll wait 0,30 then 0,20 ... Nostradamus spoke !
http://investors.amyris.com/releasedetail.cfm?ReleaseID=1015996
Always speaking about Temasek selling someone forget science and increasing revenues ...
I repeat : Temasek is selling warrants it had at 0.001 ... 14 millions more to sell then we'll see the reasons of selling ...
Why Doerr doesn't sell?
Why Fidelity is increasing position ?
Do you know share profit/ value share ?
The equation is simple,from what melo says: sell to partner(small margin)+value share = 60% margin = all the margin is at value share
Record revenues in 2016 more and more cash in 2017; real value/revenue of first product sold by Amyris will be from final product sold by partner ...
Do you know about holy grail of sweeteners and new partner in Q2?
Do you know new CFO is developing new rules of financing ?
Do you know Amyris changed MOU for it was dilutive ?
Do you know Brotas2 will be not dilutive ?
you know all ... or not ?
Very very happy if 0,30 ... time to buy a lot of this holy grail ...
Good reasons to be happy
-Almost nothing (25%TAB)to do with biofuels;
-Doubled revenues in 2016;
-Profit share model ( I hope all of you know about it) in 2017 will help Amyris to be cash flow positive for first time;
- CFO said a lot of times they never will use ATM ;
-new partner in Q2;
-13,8 million secured for 1Q2017(10 million from Nikko and 3,8 million product already sold as I heard in last ER);
-30 million in cash ( someone don't read ER ?? );
-new CFO don't use dilution to resolve problems as Raffi;
-MOU closed with 10 million profit ;
-plant expansion will not be paid by shareholders;
-evolution of DARPA project (we'll see in May);
-new project in sweeteners;
-Temasek has almost finished free shares to sell ;
-sp so low is a real opportunity of being real investors of the next Bio-Apple.
The last point is just my opinion ... all the other points are facts no words ...
P.S conversion price is fixed 3,08/shares ...
9 months for RS ? maybe ... but you know 9 months is enough for a birth !
SEC about Total ? They delayed payment for they can repurchase the note ... I'm thinking something big is coming ...
Amyris has the holy grail of sweetener !
P.S.
Yesterday no dilutive equity offering ...
Listen to CFO during ER please ... so you can learn more about the future of this company .
Remember Amyris has a value share mechanism ... real profit come after final product is sold from partner !!! very very bullish
they omissed 10 million Nikko JV ... I think manipulation of this stock is really strong ... Temasek-Amyris deal ? Dear Spider I know you were right about secret doors but thinking reasons are not the same ...
13 millions more to sell ...
why did you buy ?
'But they don't tell you in which stores, or how many' ... it's not true ... in biossance.com you can see all Sephora stores ... click 'coming soon to Sephora' !
What is the problem with changed names or new product ? They changed packs too ... Really I don't understand your doubts ... this is smart marketing !
Will they be in Sephora only in Spring ? Have you some news we don't have or are you just supposing ?
Speaking all the time of Insider selling , why Fidelity buying (new insider) is not so important ... Temasek is selling all shares it had at 0.001 (and Temasek lost a lot of money this year with its bad choices) ... now these warrants are almost finished ! We'll see ...
Why don't you speak about Liquid Farnesene Rubber Used in Car Tires for First Time ... we speak of Biologically Derived Liquid Rubber that Improves Ice Grip ... news of today (inside Dunlop winter max 02 )!
And so on ...
what about increasing demand of squalene and farnesene ?
what about Queensland deal with 26 companies potential partner ?
What about pharmaceutical, nutraceutical, cosmetic deal ?
All rubbish ? I don't think so ...
We can have different opinions but please don't lie to support your thesis.
Ok ok you are right ... only a question ... why this CEO so linked to money gave away malaria treatment for nothing ? really I don't understand ...
You always talk about him like Arsenio Lupin ...
Amyris surely did a lot of mistakes with biofuel and sp reflects but thinking it changed since 1 year and 2017 will tell us ...
P.S. a lot of convertible debt is not insider selling ...
https://www.scientificamerican.com/article/darpa-rsquo-s-biotech-chief-says-2017-will-ldquo-blow-our-minds-rdquo/#
I understand ... don't worry ...
What are you talking about ? Yesterday problems were insider selling , today you finally understood there was not insider selling but selling of convertible notes .
Yes Yes dear friend .... all we know this means dilution ... but this dilution came from wrong choices in the past and the bad dreams of a biofuel company ...
Now Amyris is changed and biofuel maybe will be future but surely not the present of this company.
Nutraceutical,pharmaceutical,cosmetic deals that you call bad will bring soon a lot of cash ... Sephora's deal alone will be a multimillion opportunity and products are great !
A lot of shot on goals in molecular research could change future ... and you know this ... one single goal and we'll speak of earnings of millions of dollars ...
Do you prefer debt without dilution ? Do you prefer more earnings and a multibillion debt like Valeant ?
Sp is not so low for you ?
Reversal split 1-20 ? What's my target price now ? Well ... I'll multiply 20times ... Long to 0 or dividends ... This is Amyris and future needs Amyris !
RC
http://investors.amyris.com/sec.cfm sec of today explains ...
Temasek is not selling so much but is still holding 64,75 million shares (only -2% since october)for it sold convertible notes ... surely a little more dilution but if all the notes convert Amyris is almost debt free ... next ER probably will reveal first time in history the company is becoming self sustained ... Let's see ...
RC
Insider selling of Temasek maybe is a simple transfer to a new strong buyer ... and remember Temasek has 60 millions shares and 2016 was not so good for its investments;Amyris is a good gain for it had shares at 0,01.
Lack of confidence ? I don't think so for it sells only at 0.8 for some reasons future will tell us .
But ... I want remember you this is an investment !
Do you believe Amyris is the future or not ?
If not why do you waste your time to write about the stupidity of us - long shareholders ?
2017 is surely year of truth and we'll see if you were right or not but surely future needs Amyris !
RC
25M unsecured credit with Guanfu closed 31th December ... I don't think all are so stupid to have confidence in this company ... Don't you think so JMO?
You have to say the truth !!! He will continue to support ... and it could be a good news... As example I Remember few months ago since Antares' CFO left ... Pps was 1$ , now over 2,30 $ ... and company is growing ...
you speak about insider selling ... they sold 1/100 of their shares for reasons you don't know ... Temasek now holds 62 millions shares and it's not selling below 0.8 ... It didn't sell over 1$ but only at 0.8 ... Surely there is some kind of manipulation but derivatives can explain the reasons for they didn't want high pps ...I repeat ... future will tell us ; this company maybe will be the future maybe not ... but surely future needs Amyris !
6 months and then 6 months ... no problem now ... 2017 will be the year of all in ..
You forget one important fact ... this is an investment not a secured bank !!! no one knows development of research in Amyris ... tomorrow could be the day of big news or never but remember ... this is an investment ... What your problem with this company ? If you don't love it I don't understand the reasons of your tweets ... you waste a lot of your time ... Happy new year !
you mean Neossance's deal is not good , you mean Guanfu's deal is not good , you mean Sephora's deal is not good , you mean refinanced debt is not good, you mean Queensland's deal is not good , you mean Kurukai's deal is not good, you mean all deals are not good(pharmaceutical, nutraceutical and so on), you mean malaria treatment is not good ... I don't know if you are right ... but future will tell us ...
you are right ... the new age of investment ... but it's not a real investment , it's only speculation for fast money ... the new age? medieval age ...
ok ok i know .. debt and dilution ... I know ... trick or treat ... I know ... repetita juvant ... but please stop writing about this company like Beagle Boys ... It's a revolutionary company with innovative ideas and a lot of deals with people believe these ideas are the future ... Few revenues ? I don't think so ... Biossance alone could be a multimillion opportunity and Sephora is the best partner ... Neossance with this joint venture will be more profitable ... and so on ... World is changing and Amyris could be the 'must have' company of the future ... It's an long investment ... I know short here are not so happy .
fake news, trick, golden doors ... all the time I read about this I smile thinking what I have in my portfolio. I don't know so well this company as maybe someone in this app ... but I really think Amyris is the future of biofuel, nutraceutical, pharmaceutical and cosmetic ... It will be not so easy but Apple's story docet ... when you change the world the world wake up later ... if not I'm happy to donate my few money for treatment of malaria ... if I'm right I'll donate a lot of my future richness ...
A license fee of $15 million was paid on July 25 to Amyris ... what about this ?